These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35847500)

  • 1. A practical strategy to develop isoform-selective near-infrared fluorescent probes for human cytochrome P450 enzymes.
    Feng L; Tian X; Yao D; Yu Z; Huo X; Tian Z; Ning J; Cui J; James TD; Ma X
    Acta Pharm Sin B; 2022 Apr; 12(4):1976-1986. PubMed ID: 35847500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLM chip - A microfluidic approach to study the mechanistic basis of cytochrome P450 inhibition using immobilized human liver microsomes.
    Pihlaja T; Kiiski I; Sikanen T
    Eur J Pharm Sci; 2024 Jun; 197():106773. PubMed ID: 38641124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Design Strategy to Construct the Near-Infrared Fluorescent Probe for Selectively Sensing Human Cytochrome P450 2J2.
    Ning J; Liu T; Dong P; Wang W; Ge G; Wang B; Yu Z; Shi L; Tian X; Huo X; Feng L; Wang C; Sun C; Cui J; James TD; Ma X
    J Am Chem Soc; 2019 Jan; 141(2):1126-1134. PubMed ID: 30525564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying the Dominant Contribution of Human Cytochrome P450 2J2 to the Metabolism of Rivaroxaban, an Oral Anticoagulant.
    Zhao T; Chen Y; Wang D; Wang L; Dong P; Zhao S; Wang C; Meng Q; Sun H; Liu K; Wu J
    Cardiovasc Drugs Ther; 2022 Feb; 36(1):121-129. PubMed ID: 33411110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An automated cocktail method for in vitro assessment of direct and time-dependent inhibition of nine major cytochrome P450 enzymes - application to establishing CYP2C8 inhibitor selectivity.
    Kahma H; Aurinsalo L; Neuvonen M; Katajamäki J; Paludetto MN; Viinamäki J; Launiainen T; Filppula AM; Tornio A; Niemi M; Backman JT
    Eur J Pharm Sci; 2021 Jul; 162():105810. PubMed ID: 33753217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cytochrome P450 inhibition assays for drug discovery using human liver microsomes with LC-MS, rhCYP450 isozymes with fluorescence, and double cocktail with LC-MS.
    Di L; Kerns EH; Li SQ; Carter GT
    Int J Pharm; 2007 Apr; 335(1-2):1-11. PubMed ID: 17137735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case Study 9: Probe-Dependent Binding Explains Lack of CYP2C9 Inactivation by 1-Aminobenzotriazole (ABT).
    Sodhi JK; Halladay JS
    Methods Mol Biol; 2021; 2342():765-779. PubMed ID: 34272716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.
    Lee CA; Jones JP; Katayama J; Kaspera R; Jiang Y; Freiwald S; Smith E; Walker GS; Totah RA
    Drug Metab Dispos; 2012 May; 40(5):943-51. PubMed ID: 22328583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an in vitro drug-drug interaction assay to simultaneously monitor five cytochrome P450 isoforms and performance assessment using drug library compounds.
    Zientek M; Miller H; Smith D; Dunklee MB; Heinle L; Thurston A; Lee C; Hyland R; Fahmi O; Burdette D
    J Pharmacol Toxicol Methods; 2008; 58(3):206-14. PubMed ID: 18634893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic Study of Icaritin-Induced Inactivation of Cytochrome P450 2C9.
    Chen X; Han L; Zhao Y; Huang H; Pan H; Zhang C; Chen H; Sun S; Yao S; Chen X; Zhang Y
    Drug Metab Dispos; 2023 Jun; 51(6):771-781. PubMed ID: 36863865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic assessment of a five-probe cocktail for CYPs 1A2, 2C9, 2C19, 2D6 and 3A.
    Turpault S; Brian W; Van Horn R; Santoni A; Poitiers F; Donazzolo Y; Boulenc X
    Br J Clin Pharmacol; 2009 Dec; 68(6):928-35. PubMed ID: 20002088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of multiple cytochrome P450 isoenzymes in drug interactions between ritonavir and direct oral anticoagulants.
    Tamemoto Y; Shibata Y; Hashimoto N; Sato H; Hisaka A
    Drug Metab Pharmacokinet; 2023 Dec; 53():100498. PubMed ID: 37778107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of cytochrome P450 isoenzyme activity in sheep liver and placental microsomes.
    Meakin AS; Amirmostofian M; Darby JR; Holman SL; Morrison JL; Wiese MD
    Placenta; 2023 Jan; 131():82-89. PubMed ID: 36527743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence-Based High-Throughput Assays for Investigating Cytochrome P450 Enzyme-Mediated Drug-Drug Interactions.
    He R; Dai Z; Finel M; Zhang F; Tu D; Yang L; Ge G
    Drug Metab Dispos; 2023 Oct; 51(10):1254-1272. PubMed ID: 37349113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliable high-throughput method for inhibition assay of 8 cytochrome P450 isoforms using cocktail of probe substrates and stable isotope-labeled internal standards.
    Kozakai K; Yamada Y; Oshikata M; Kawase T; Suzuki E; Haramaki Y; Taniguchi H
    Drug Metab Pharmacokinet; 2012; 27(5):520-9. PubMed ID: 22498647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target Enzyme-Activated Two-Photon Fluorescent Probes: A Case Study of CYP3A4 Using a Two-Dimensional Design Strategy.
    Ning J; Wang W; Ge G; Chu P; Long F; Yang Y; Peng Y; Feng L; Ma X; James TD
    Angew Chem Int Ed Engl; 2019 Jul; 58(29):9959-9963. PubMed ID: 31099941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a method to determine cytochrome P450 1A2, 2C9, 2D6 and 3A4 activity sheep hepatic microsomes.
    McBride GM; Soo JY; Varcoe T; Morrison JL; Wiese MD
    J Pharmacol Toxicol Methods; 2020; 106():106934. PubMed ID: 33080390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fondaparinux sodium is not metabolised in mammalian liver fractions and does not inhibit cytochrome P450-mediated metabolism of concomitant drugs.
    Lieu C; Shi J; Donat F; Van Horn R; Brian W; Newton J; Delbressine L; Vos R
    Clin Pharmacokinet; 2002; 41 Suppl 2():19-26. PubMed ID: 12383041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of ten cytochrome P450 enzyme activities with 12 probe substrates in human liver microsomes using cocktail incubation and liquid chromatography-tandem mass spectrometry.
    Kim HJ; Lee H; Ji HK; Lee T; Liu KH
    Biopharm Drug Dispos; 2019 Apr; 40(3-4):101-111. PubMed ID: 30730576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Size- and time-dependent alteration in metabolic activities of human hepatic cytochrome P450 isozymes by gold nanoparticles via microsomal coincubations.
    Ye M; Tang L; Luo M; Zhou J; Guo B; Liu Y; Chen B
    Nanoscale Res Lett; 2014; 9(1):642. PubMed ID: 25520592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.